These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 18400418)
1. Pro-inflammatory cytokines and prostate-specific antigen in hyperplasia and human prostate cancer. Bouraoui Y; Ricote M; García-Tuñón I; Rodriguez-Berriguete G; Touffehi M; Rais NB; Fraile B; Paniagua R; Oueslati R; Royuela M Cancer Detect Prev; 2008; 32(1):23-32. PubMed ID: 18400418 [TBL] [Abstract][Full Text] [Related]
2. [Prostatic specific antigen (PS), pro-inflammatory cytokines, and prostatic pathology (benign prostatic hyperplasia and cancer). Relationship with malignancy]. Cansino Alcaide JR; Vera San Martín R; Rodríguez de Bethencourt Codes F; Bouraoui Y; Rodríguez Berriguete G; Oueslati R; Pérez-Utrilla M; De la Peña Barthel J; Paniagua Gómez-Alvarez R; Royuela García M Arch Esp Urol; 2009 Jun; 62(5):359-66. PubMed ID: 19721171 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate. Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520 [TBL] [Abstract][Full Text] [Related]
4. Profile of NF-κBp(65/NFκBp50) among prostate specific antigen sera levels in prostatic pathologies. Bouraoui Y; Ben Jemaa A; Rodriguez G; Ben Rais N; Fraile B; Paniagua R; Sellemi S; Royuela M; Oueslati R Pathol Biol (Paris); 2012 Oct; 60(5):301-5. PubMed ID: 21889270 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1Ra) in prostate carcinoma. Ricote M; García-Tuñón I; Bethencourt FR; Fraile B; Paniagua R; Royuela M Cancer; 2004 Apr; 100(7):1388-96. PubMed ID: 15042672 [TBL] [Abstract][Full Text] [Related]
6. Prostate specific antigen in the expressed prostatic fluid of men with benign prostatic hyperplasia and prostate carcinoma. Kim ED; Smith ND; Grayhack JT J Urol; 1995 Nov; 154(5):1802-5. PubMed ID: 7563351 [TBL] [Abstract][Full Text] [Related]
7. Elevation of cytokine levels in cachectic patients with prostate carcinoma. Pfitzenmaier J; Vessella R; Higano CS; Noteboom JL; Wallace D; Corey E Cancer; 2003 Mar; 97(5):1211-6. PubMed ID: 12599227 [TBL] [Abstract][Full Text] [Related]
8. The p38 transduction pathway in prostatic neoplasia. Ricote M; García-Tuñón I; Bethencourt F; Fraile B; Onsurbe P; Paniagua R; Royuela M J Pathol; 2006 Feb; 208(3):401-7. PubMed ID: 16369914 [TBL] [Abstract][Full Text] [Related]
9. A precursor form of prostate-specific antigen is more highly elevated in prostate cancer compared with benign transition zone prostate tissue. Mikolajczyk SD; Millar LS; Wang TJ; Rittenhouse HG; Marks LS; Song W; Wheeler TM; Slawin KM Cancer Res; 2000 Feb; 60(3):756-9. PubMed ID: 10676664 [TBL] [Abstract][Full Text] [Related]
10. Analysis of the inflammatory network in benign prostate hyperplasia and prostate cancer. König JE; Senge T; Allhoff EP; König W Prostate; 2004 Feb; 58(2):121-9. PubMed ID: 14716737 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of plasma interleukin-8 concentration in patients with prostate cancer and benign prostate hyperplasia. Dehghani M; Mostafavi-Pour Z; Lotfi M; Shakeri S Iran J Immunol; 2009 Jun; 6(2):92-8. PubMed ID: 19561378 [TBL] [Abstract][Full Text] [Related]
12. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia. Zhao Z; Liu J; Li S; Shen W Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463 [TBL] [Abstract][Full Text] [Related]
13. Cytokine profiling identifies an interaction of IL-6 and IL-1α to drive PSMA-PSA prostate clones. Jemaa AB; Bouraoui Y; Rais NB; Nouira Y; Oueslati R Immunobiology; 2016 Dec; 221(12):1424-1431. PubMed ID: 27451139 [TBL] [Abstract][Full Text] [Related]
14. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia. Penna G; Mondaini N; Amuchastegui S; Degli Innocenti S; Carini M; Giubilei G; Fibbi B; Colli E; Maggi M; Adorini L Eur Urol; 2007 Feb; 51(2):524-33; discussion 533. PubMed ID: 16905241 [TBL] [Abstract][Full Text] [Related]
15. Detection of prostate-specific antigen coupled to immunoglobulin M in prostate cancer patients. Beneduce L; Prayer-Galetti T; Giustinian AM; Gallotta A; Betto G; Pagano F; Fassina G Cancer Detect Prev; 2007; 31(5):402-7. PubMed ID: 18035503 [TBL] [Abstract][Full Text] [Related]
16. Whole blood selenium levels (WBSL) in patients with prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy male inhabitants (HMI) and prostatic tissue selenium levels (PTSL) in patients with PC and BPH. Muecke R; Klotz T; Giedl J; Buentzel J; Kundt G; Kisters K; Prott FJ; Micke O Acta Oncol; 2009; 48(3):452-6. PubMed ID: 18855158 [TBL] [Abstract][Full Text] [Related]
17. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy. Ohyama C; Hosono M; Nitta K; Oh-eda M; Yoshikawa K; Habuchi T; Arai Y; Fukuda M Glycobiology; 2004 Aug; 14(8):671-9. PubMed ID: 15044396 [TBL] [Abstract][Full Text] [Related]
18. Postoperative PSA and PSA velocity identify presence of prostate cancer after various surgical interventions for benign prostatic hyperplasia. Helfand BT; Anderson CB; Fought A; Kim DY; Vyas A; McVary KT Urology; 2009 Jul; 74(1):177-83. PubMed ID: 19428074 [TBL] [Abstract][Full Text] [Related]
19. Differential percentage of serum prostate-specific antigen subforms suggests a new way to improve prostate cancer diagnosis. Sarrats A; Comet J; Tabarés G; Ramírez M; Aleixandre RN; de Llorens R; Peracaula R Prostate; 2010 Jan; 70(1):1-9. PubMed ID: 19670261 [TBL] [Abstract][Full Text] [Related]
20. Serum resistin levels in benign prostate hyperplasia and non-metastatic prostate cancer: possible role in cancer progression. Housa D; Vernerova Z; Heracek J; Cechak P; Rosova B; Kuncova J; Haluzik M Neoplasma; 2008; 55(5):442-6. PubMed ID: 18665756 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]